hPSCreg
This website uses cookies to keep track of login sessions and for internal Piwik Statistics. See our Privacy Policy for details. This website uses cookies, learn more

Search results

Sort by:

Filter by:

  1. AAUe001-A (CLS1)

    Denmark Aalborg University (AAU)

  2. AAUe002-A (CLS2)

    Denmark Aalborg University (AAU)

  3. AAUe003-A (CLS3)

    Denmark Aalborg University (AAU)

  4. AAUe004-A (CLS4)

    Denmark Aalborg University (AAU)

  5. ACTe001-A (Ma01)

    United States Advanced Cell Technology, Inc. - Cellular Reprogramming unit (ACT)

  6. ACTe002-A (Ma09)

    United States Advanced Cell Technology, Inc. - Cellular Reprogramming unit (ACT)

  7. ACTe003-A (ACT-14)

    United States Advanced Cell Technology, Inc. - Cellular Reprogramming unit (ACT)

  8. AXORe001-A (Shef-1)

    United Kingdom Axordia Ltd. (AXOR)

  9. AXORe002-A (Shef-2)

    United Kingdom Axordia Ltd. (AXOR)

  10. AXORe004-A (Shef-4)

    United Kingdom Axordia Ltd. (AXOR)

  11. AXORe005-A (Shef-5)

    United Kingdom Axordia Ltd. (AXOR)

  12. AXORe007-A (Shef-7)

    United Kingdom Axordia Ltd. (AXOR)

  13. BCHe001-A (CHB-7)

    United States Children's Hospital (BCH)

  14. BCHe002-A (CHB-8)

    United States Children's Hospital (BCH)

  15. BCHe003-A (CHB-9)

    United States Children's Hospital (BCH)

  16. BCHe004-A (CHB-10)

    United States Children's Hospital (BCH)

  17. BCHe005-A (CHB-11)

    United States Children's Hospital (BCH)

  18. BCHe006-A (CHB-12)

    United States Children's Hospital (BCH)

  19. BCRTi001-A (P01-1)

    Germany Berlin-Brandenburg Center for Regenerative Therapies (BCRT)
    Disease:

    Fibrodysplasia ossificans progressiva

  20. BCRTi002-A (P02-1)

    Germany Berlin-Brandenburg Center for Regenerative Therapies (BCRT)
    Disease:

    Fibrodysplasia ossificans progressiva

  21. BCRTi004-A

    Germany Berlin-Brandenburg Center for Regenerative Therapies (BCRT)
    Disease:

    Normal (normalities, health, normalcy, normality)

  22. BCRTi005-A

    Germany Berlin-Brandenburg Center for Regenerative Therapies (BCRT)
    Disease:

    Normal (normalities, health, normalcy, normality)

  23. BIHi001-A (BCRT-3 and BCRT#1)

    Germany Berlin Institute of Health (BIH)
    Disease:

    Normal (normalities, health, normalcy, normality)

  24. BIHi002-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Autosomal recessive osteopetrosis 4

  25. BIHi004-A (NHDF Epi5 Cl5 iPSC)

    Germany Berlin Institute of Health (BIH)
    Disease:

    Normal (normalities, health, normalcy, normality)

  26. BIHi005-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Normal (normalities, health, normalcy, normality)

  27. BIHi005-A-4

    Germany Berlin Institute of Health (BIH)
    Disease:

    Myocardial infarction

  28. BIHi005-A-5

    Germany Berlin Institute of Health (BIH)
    Disease:

    Alzheimer's disease

  29. BIHi006-D

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  30. BIHi007-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  31. BIHi008-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  32. BIHi009-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  33. BIHi010-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  34. BIHi011-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  35. BIHi012-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  36. BIHi015-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  37. BIHi016-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  38. BIHi017-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  39. BIHi018-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  40. BIHi019-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  41. BIHi024-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  42. BIHi025-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  43. BIHi028-B

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  44. BIHi029-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  45. BIHi030-C

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  46. BIHi031-B

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  47. BIHi038-B

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  48. WTSIi227-A-1 (WETU LRP2 KO)

    Germany Berlin Institute of Health (BIH)
    Disease:

    Donnai-barrow syndrome

  49. STBCi006-A-1 (ApoE KO)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  50. STBCi006-A-3 (ApoE 3/3)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  51. STBCi006-A-4 (ApoE 3/4)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  52. BIONi010-A (K1P53)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  53. BIONi010-B (K2P53 and BIONi010-B)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  54. BIONi010-C (BIONi010-C and K3P53)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  55. BIONi010-C-2 (BIONi010-C ApoE E3/E3 #H8 P32)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  56. BIONi010-C-3 (BIONi010-C ApoE KO #KO30 P30)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  57. BIONi010-C-4 (BIONi010-C ApoE E4/E4 #B44 P27)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  58. BIONi010-C-5 (BIONi010-C CD33 E2del #N14 P26)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  59. BIONi010-C-6 (BIONi010-C ApoE E2/E2)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  60. BIONi010-C-7 (BIONi010-C Trem2 R47H)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  61. BIONi010-C-8 (BIONi010-C Trem2 T66M and #Y5-80)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  62. BIONi010-C-9 (BIONi010-C CD33 KO)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  63. BIONi010-C-10 (HNF1AP291fsinsC +/- 54-5)

    Denmark Bioneer (BION)
    Disease:

    Mody

  64. BIONi010-C-11 (HNF1AP291fsinsC -/- 66-1)

    Denmark Bioneer (BION)
    Disease:

    Mody

  65. BIONi010-C-12 (HNF4ApR309C -/- 2-4)

    Denmark Bioneer (BION)
    Disease:

    Mody

  66. BIONi010-C-13 (BIONi010-C + NGN2 #I7-26)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  67. BIONi010-C-15 (BIONi010-C +dox inducible NGN2-GFP)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  68. BIONi010-C-17 (BIONi010-C TREM2 KO)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  69. BIONi010-C-18 (BIONi010-C TBK1 KO)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  70. BIONi010-C-19 (BIONi010-C IKBKE KO)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  71. BIONi010-C-24 (BIONi010-C Dox a-syn)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  72. BIONi010-C-25 (BIONi010-C heterozygous TREM2 KO)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  73. UKBi011-A-1 (iLB-AD + ApoE KO)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  74. UKBi011-A-2 (ApoE 2/2)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  75. UKBi011-A-3 (ApoE 3/3)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  76. UKBi011-A-4 (ApoE 3/4)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  77. BIONi013-A (H240715 47-1 and SAMEA4342502)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  78. BIONi014-A (H270715 47-1 and SAMEA4342566)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  79. BIONi015-A (H280715 47-1 and SAMEA4342649)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  80. BIONi016-A (H310715 47-1)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  81. BIONi017-A (H030815 47-1 and SAMEA4451663)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  82. BIONi018-A (H050815 48-4 and SAMEA4451665)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  83. BIONi019-A (H060815 48-3 and SAMEA4451667)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  84. BIONi020-A (H070815 47-2 and SAMEA4451669)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  85. BIONi021-A (H100815 48-2 and SAMEA4451671)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  86. BIONi022-A (H110815 47-2 and SAMEA4451673)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  87. BIONi023-A (H130815 47-4 and SAMEA4454014)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  88. BIONi024-A (H170815 47-2 and SAMEA4454016)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  89. BIONi025-A (H210815 48-3 and SAMEA4454018)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  90. BIONi026-A (H300715 48-3)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  91. BIONi027-A (H040815 48-1 and SAMEA4455499)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  92. BIONi028-A (H120815 48-1 and SAMEA4455501)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  93. BIONi029-A (H190815 47-1 and SAMEA4455503)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  94. BIONi030-A (H200815 47-1 and SAMEA4455505)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  95. BIONi031-A (H240815 48-2 and SAMEA4455507)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  96. BIONi032-A (H250815 48-1 and SAMEA4455509)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  97. BIONi033-A (H180615 and SAMEA4563389)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  98. BIONi034-A (H290715 and SAMEA4563391)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  99. BIONi035-A (H180815 and SAMEA4563393)

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  100. BIONi037-A (16423 ApoE3/3 (control line))

    Denmark Bioneer (BION)
    Disease:

    Normal (normalities, health, normalcy, normality)

  101. BIONi037-A-1 (16423 ApoE KO)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  102. BIOTi001-A (BIOT-7183-PSEN1)

    Hungary BioTalentum Ltd. (BIOT)
    Disease:

    Alzheimer's disease

  103. BJMUe001-A (PKU1)

    China Peking University Third Hospital (BJMU)

  104. BJMUe002-A (PKU2)

    China Peking University Third Hospital (BJMU)

  105. BJMUe003-A (B4)

    China Peking University Third Hospital (BJMU)

  106. BJMUe004-A (B7)

    China Peking University Third Hospital (BJMU)

  107. BIONi037-A-2 (BIONi037-A ApoE2/2 #M10-7)

    Denmark Bioneer (BSC)
    Disease:

    Alzheimer's disease

  108. BIONi037-A-3 (BIONi037-A ApoE3/4 #P10-22)

    Denmark Bioneer (BSC)
    Disease:

    Alzheimer's disease

  109. BIONi037-A-4 (BIONi037-A ApoE4/4 #I10-53)

    Denmark Bioneer (BSC)
    Disease:

    Alzheimer's disease

  110. CAMi001-A (KiPS c1)

    United Kingdom University of Cambridge (CAM)
    Disease:

    Normal (normalities, health, normalcy, normality)

  111. CAMi002-A (FiPS 2a)

    United Kingdom University of Cambridge (CAM)
    Disease:

    Normal (normalities, health, normalcy, normality)

  112. CAMi002-B (FiPS 2b)

    United Kingdom University of Cambridge (CAM)
    Disease:

    Normal (normalities, health, normalcy, normality)

  113. CAMi002-C (FiPS 2c)

    United Kingdom University of Cambridge (CAM)
    Disease:

    Normal (normalities, health, normalcy, normality)

  114. CAMi004-A (AdiPS 1)

    United Kingdom University of Cambridge (CAM)
    Disease:

    Normal (normalities, health, normalcy, normality)

  115. CAMi005-A (O27Tat)

    United Kingdom University of Cambridge (CAM)
    Disease:

    Normal (normalities, health, normalcy, normality)

  116. CAMi005-B (2F8)

    United Kingdom University of Cambridge (CAM)
    Disease:

    Normal (normalities, health, normalcy, normality)

  117. CAMe001-A (HNES-1 and HNES1)

    United Kingdom University of Cambridge (CAM)
    Disease:

    Normal (normalities, health, normalcy, normality)

  118. CAMe002-A (HNES-3 and HNES3)

    United Kingdom University of Cambridge (CAM)
    Disease:

    Normal (normalities, health, normalcy, normality)

  119. CBi001-A (XLC-348)

    United States Creative Bioarray (CB)
    Disease:

    Schizophrenia

  120. CBi002-A (XLC303 and CSC-C00122)

    United States Creative Bioarray (CB)
    Disease:

    Schizophrenia

  121. TMOi001-A-1 (hiPSC-CD34-GFP-3G6)

    Austria Children's Cancer Research Institute St. Anna Kinderkrebsforschung e. V. (CCRI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  122. CDIi001-A (01279)

    United States Cellular Dynamics International, a FUJIFILM Company (CDI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  123. CDIi004-A (11713)

    United States Cellular Dynamics International, a FUJIFILM Company (CDI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  124. CEBe001-A (FC018)

    Sweden Cellartis AB Sweden (CEB)
    Disease:

    Klinefelter's syndrome

  125. CEBe002-A (AS034)

    Sweden Cellartis AB Sweden (CEB)

  126. CEBe002-A-1 (AS034.1)

    Sweden Cellartis AB Sweden (CEB)

  127. CEBe002-A-2 (AS034.2)

    Sweden Cellartis AB Sweden (CEB)

  128. CEBe002-A-3 (AS034.1.1)

    Sweden Cellartis AB Sweden (CEB)

  129. CEBe006-A (AS038)

    Sweden Cellartis AB Sweden (CEB)

  130. CEBe007-A (SA046)

    Sweden Cellartis AB Sweden (CEB)

  131. CEBe008-A (AS079)

    Sweden Cellartis AB Sweden (CEB)

  132. CEBe009-A (SA085)

    Sweden Cellartis AB Sweden (CEB)

  133. CEBe010-A (SA094)

    Sweden Cellartis AB Sweden (CEB)

  134. CEBe011-A (SA111)

    Sweden Cellartis AB Sweden (CEB)

  135. CEBe012-A (SA121)

    Sweden Cellartis AB Sweden (CEB)

  136. CEBe013-A (SA142)

    Sweden Cellartis AB Sweden (CEB)

  137. CEBe014-A (SA167)

    Sweden Cellartis AB Sweden (CEB)

  138. CEBe015-A (SA181)

    Sweden Cellartis AB Sweden (CEB)

  139. CEBe016-A (SA191)

    Sweden Cellartis AB Sweden (CEB)

  140. CEBe017-A (SA196)

    Sweden Cellartis AB Sweden (CEB)

  141. CEBe018-A (SA202)

    Sweden Cellartis AB Sweden (CEB)

  142. CEBe019-A (SA203)

    Sweden Cellartis AB Sweden (CEB)

  143. CEBe020-A (SA211)

    Sweden Cellartis AB Sweden (CEB)

  144. CEBe021-A (SA218)

    Sweden Cellartis AB Sweden (CEB)

  145. CEBe022-A (SA240)

    Sweden Cellartis AB Sweden (CEB)

  146. CEBe023-A (SA348)

    Sweden Cellartis AB Sweden (CEB)

  147. CEBe024-A (SA279)

    Sweden Cellartis AB Sweden (CEB)

  148. CEBe025-A (SA352)

    Sweden Cellartis AB Sweden (CEB)

  149. CEBe026-A (SA399)

    Sweden Cellartis AB Sweden (CEB)

  150. CEBe027-A (SA461)

    Sweden Cellartis AB Sweden (CEB)

  151. CEBe028-A (SA502)

    Sweden Cellartis AB Sweden (CEB)

  152. CEBe029-A (SA506)

    Sweden Cellartis AB Sweden (CEB)

  153. CEBe030-A (SA521)

    Sweden Cellartis AB Sweden (CEB)

  154. CEBe031-A (SA540)

    Sweden Cellartis AB Sweden (CEB)

  155. CEBe032-A (SA611)

    Sweden Cellartis AB Sweden (CEB)

  156. CEBe033-A (SA001)

    Sweden Cellartis AB Sweden (CEB)

  157. CEBe034-A (SA002)

    Sweden Cellartis AB Sweden (CEB)
    Disease:

    Patau syndrome

  158. CEBe034-A-1 (SA002.5)

    Sweden Cellartis AB Sweden (CEB)
    Disease:

    Patau syndrome

  159. CEBe035-A (SA003)

    Sweden Cellartis AB Sweden (CEB)

  160. CENSOi001-B (FB78R2c2 and CENSOi249)

    United Kingdom Censo Biotechnologies (CENSO)
    Disease:

    Dmd

  161. CENSOi002-B (FB74R2c4 and CENSOi261)

    United Kingdom Censo Biotechnologies (CENSO)
    Disease:

    Dmd

  162. CENSOi003-B (FB79R2c6 and CENSOi258)

    United Kingdom Censo Biotechnologies (CENSO)
    Disease:

    Dmd

  163. CENSOi005-A (FB76R2c5 and CENSOi245)

    United Kingdom Censo Biotechnologies (CENSO)
    Disease:

    Dmd

  164. CENSOi007-A (FB75R2c5 and CENSOi255)

    United Kingdom Censo Biotechnologies (CENSO)
    Disease:

    Dmd

  165. CENSOi008-A (FB77R2c3 and CENSOi260)

    United Kingdom Censo Biotechnologies (CENSO)
    Disease:

    Myotonic dystrophy type 1

  166. CHAe001-A (CHA-hES3)

    South Korea Pochon CHA University (CHA)

  167. CHAe002-A (CHA-hES4)

    South Korea Pochon CHA University (CHA)

  168. CHOPi001-A (CHOPJMML1854)

    United States The Children's Hospital of Philadelphia (CHOP)
    Disease:

    Juvenile myelomonocytic leukemia

  169. CHULAe001-A (Chula2.hES)

    Thailand Chulalongkorn University (CHULA)

  170. CHUQi001-A (522-2666-2 and SAMEA104271492)

    Canada CHU de Québec-Université Laval Research Center (CHUQ)
    Disease:

    Myotonic dystrophy type 1

  171. CIMHi001-A (CIMHi44f028#4)

    Germany Central Institute of Mental Health (CIMH)
    Disease:

    Normal (normalities, health, normalcy, normality)

  172. CIMHi002-A (CIMHi29m067#3)

    Germany Central Institute of Mental Health (CIMH)
    Disease:

    Normal (normalities, health, normalcy, normality)

  173. CIMHi003-A (CIMHi23m035#2)

    Germany Central Institute of Mental Health (CIMH)
    Disease:

    Normal (normalities, health, normalcy, normality)

  174. CMFTe001-A (Man-2)

    United Kingdom Central Manchester and Manchester Children's University Hospitals NHS (CMFT)

  175. CMFTe002-A (Man-12)

    United Kingdom Central Manchester and Manchester Children's University Hospitals NHS (CMFT)
    Disease:

    Normal (normalities, health, normalcy, normality)

  176. CMFTe003-A (Man-14)

    United Kingdom Central Manchester and Manchester Children's University Hospitals NHS (CMFT)
    Disease:

    Normal (normalities, health, normalcy, normality)

  177. CMFTe004-A (Man-16)

    United Kingdom Central Manchester and Manchester Children's University Hospitals NHS (CMFT)
    Disease:

    Normal (normalities, health, normalcy, normality)

  178. CRMi001-A (NCRM-5 and NL-5)

    United States National Institutes of Health - Center for Regenerative Medicine (CRM)
    Disease:

    Normal (normalities, health, normalcy, normality)

  179. CRMi003-A (NCRM-1 and NL-1)

    United States National Institutes of Health - Center for Regenerative Medicine (CRM)
    Disease:

    Normal (normalities, health, normalcy, normality)

  180. CRMi004-A (CR0000007, NCRM-2 and ND50030)

    United States National Institutes of Health - Center for Regenerative Medicine (CRM)
    Disease:

    Normal (normalities, health, normalcy, normality)

  181. CRMi005-A (CR0000011, ND50021 and ND1.4)

    United States National Institutes of Health - Center for Regenerative Medicine (CRM)
    Disease:

    Normal (normalities, health, normalcy, normality)

  182. CRTDi001-A (T12.9 and C1-1)

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Normal (normalities, health, normalcy, normality)

  183. CSSi001-A (Joub03cl2 and COR419)

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Joubert syndrome

  184. CSSi002-A (HD8yrs)

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Juvenile huntington disease

  185. CSSi003-A (COL04 clE2)

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Smith-magenis syndrome

  186. CSSi004-A (HD256.05 cl1)

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Huntington disease

  187. CSSi005-A (COL03 cl.C3)

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Normal (normalities, health, normalcy, normality)

  188. CSSi006-A

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Huntington disease

  189. CSSi007-A (Joub07 cl1 and COR11-NG708)

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Joubert syndrome

  190. CSSi008-A (AT214-01-02)

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Dentatorubral pallidoluysian atrophy

  191. CSUe001-A (chESC-3 (H3))

    China Central South University (CSU)

  192. CSUe004-A (chHES-20)

    China Central South University (CSU)

  193. CSUe005-A (chHES-22)

    China Central South University (CSU)

  194. WAe009-A-10 (EBNA1+H9 and H9-EBNA)

    China Central South University (CSU)
    Disease:

    Normal (normalities, health, normalcy, normality)

  195. CUBi001-A

    Germany Charité - Universitätsmedizin Berlin (CUB)

  196. CUBi002-B

    Germany Charité - Universitätsmedizin Berlin (CUB)

  197. DALCe001-A (ReliCellhES1)

    India Dhirubhai Ambani Life Sciences Center (DALC)

  198. DANi001-C (iPS-CCD-C3)

    Denmark Danish Research Institute of Translational Neuroscience (DAN)
    Disease:

    Normal (normalities, health, normalcy, normality)

  199. EDi001-A (AST22, AST23 and SAMEA3319992)

    United States University of Edinburgh (ED)
    Disease:

    Parkinson's disease

  200. EDi001-A-1 (AST22-C and AST23-C)

    United States University of Edinburgh (ED)
    Disease:

    Parkinson's disease

  201. EDi001-A-2 (AST23-1KO-3, AST22-1KO-3, AST-23_SCAKO Clone 3 and AST-22_SNCAKO Clone 3)

    United States University of Edinburgh (ED)
    Disease:

    Parkinson's disease

  202. EDi001-A-3 (AST23_SNCAKO Clone 1, AST22-1KO-1, AST23-1KO-1 and AST22_SNCAKO Clone 1)

    United States University of Edinburgh (ED)
    Disease:

    Parkinson's disease

  203. EDi001-A-4 (AST22-2KO-6, AST23_SNCAKO Clone 6, AST22_SNCAKO Clone 6 and AST23-2KO-6)

    United States University of Edinburgh (ED)
    Disease:

    Parkinson's disease

  204. EDi002-A (NAS2)

    United States University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  205. EDi008-B (G51D-4, EDINi008-B, EDIi008-B and SAMEA3174606)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Parkinson's disease

  206. EDi010-A (RCi136)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  207. EDi010-B (RCi138)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  208. EDi011-A (RCi139)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  209. EDi011-B (RCi140)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  210. EDi011-C (RCi141)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  211. EDi012-A (RCi163)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  212. EDi012-B (RCi164)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  213. EDi012-C (RCi165)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  214. EDi013-A (RCi192)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  215. EDi013-B (RCi193)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  216. EDi013-C (RCi214)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  217. EDi014-A (RCi175)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Unipolar depression

    Disease:

    Anti-social behavior

  218. EDi014-B (RCi185)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Unipolar depression

    Disease:

    Anti-social behavior

  219. EDi015-A (RCi176)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Unipolar depression

  220. EDi015-B (RCi183)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Unipolar depression

  221. EDi015-C (RCi184)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Unipolar depression

  222. EDi016-A (RCi189)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  223. EDi016-C (RCi191)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  224. EDi017-A (RCi174)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  225. EDi017-B (RCi181)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  226. EDi017-C (RCi182)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  227. EDi018-A (RCi211)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  228. EDi018-B (RCi212)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  229. EDi018-C (RCi213)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  230. EDi019-A (RCi166)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  231. EDi019-B (RCi167)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  232. EDi019-C (RCi168)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  233. EDi021-A (CS0395iCTR-LBCn3)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  234. EDi022-A (CS0617iCTR-LBCn1)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  235. EDi023-A (CS0791iCTR-LBCn1)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (normalities, health, normalcy, normality)

  236. EDe001-A (RH 1)

    United Kingdom University of Edinburgh (ED)

  237. EDe002-A (RH 3)

    United Kingdom University of Edinburgh (ED)

  238. EDe003-A (RH 4)

    United Kingdom University of Edinburgh (ED)

  239. EDe004-A (RH 5)

    United Kingdom University of Edinburgh (ED)

  240. EDe005-A (RH 6)

    United Kingdom University of Edinburgh (ED)

  241. EDe006-A (RH 7)

    United Kingdom University of Edinburgh (ED)

  242. EDe008-A (Edi 1)

    United Kingdom University of Edinburgh (ED)

  243. EDe009-A (Edi 2)

    United Kingdom University of Edinburgh (ED)

  244. EDe010-A (Edi 3)

    United Kingdom University of Edinburgh (ED)

  245. EDe011-A (Edi 4)

    United Kingdom University of Edinburgh (ED)

  246. EPFLi001-A (hiPS43)

    Switzerland Swiss Federal Institute of Technology (EPFL)
    Disease:

    Normal (normalities, health, normalcy, normality)

  247. EPFLi002-A (hiPS9)

    Switzerland Swiss Federal Institute of Technology (EPFL)
    Disease:

    Normal (normalities, health, normalcy, normality)

  248. EPFLi003-A (hiPS6)

    Switzerland Swiss Federal Institute of Technology (EPFL)
    Disease:

    Normal (normalities, health, normalcy, normality)

  249. EPFLi004-A (hiPS2)

    Switzerland Swiss Federal Institute of Technology (EPFL)
    Disease:

    Normal (normalities, health, normalcy, normality)

  250. EPFLi005-A (hiPS45)

    Switzerland Swiss Federal Institute of Technology (EPFL)
    Disease:

    Normal (normalities, health, normalcy, normality)

  251. EPFLi006-A (hiPS14)

    Switzerland Swiss Federal Institute of Technology (EPFL)
    Disease:

    Normal (normalities, health, normalcy, normality)

  252. ESi001-A (SPO2#1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Parkinson's disease

  253. ESi002-A (SP08#1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Parkinson's disease

  254. ESi003-A ([CRTRd]FiPS3819-4F-2)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    X-linked creatine transporter deficiency

  255. ESi004-A ([GD]FiPS-4F-21c)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Gaucher disease

  256. ESi005-A (cFA404-KiPS4F-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Fanconi anemia

  257. ESi005-B (cFA404-KiPS4F-3)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Fanconi anemia

  258. ESi006-A (SP13#4)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Parkinson's disease

  259. ESi007-A (CBiPS1sv-4F-40)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  260. ESi008-A (KiPS4F-8)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  261. ESi008-B (KiPS3F-7)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  262. ESi028-A (KiPS4F-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  263. ESi030-A (GA-FiPS4F)

    Spain Spanish Stem Cell Bank (ES)

  264. ESi031-A (XFiPS-F44-3F-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  265. ESi031-B (FiPS-3F-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  266. ESi031-C (FiPS-4F-8)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  267. ESi031-D (FiPS-4F-7)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  268. ESi032-A (XFiPS-F44-3F-2)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  269. ESi033-A (CBiPS6-2F-4)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  270. ESi034-A (CBiPS30-4F-3)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  271. ESi034-B (CBiPS30-4F-5)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  272. ESi035-A (AD]FiPSAG07645-4F-17)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Alzheimer's disease

  273. ESi036-A ([CRTRd]FiPS3067-4F-9)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Creatine transporter deficiency

  274. ESi037-A (HKiPS-4F)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  275. ESi038-A (CBiPS32-2F-2)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  276. ESi038-B (CBiPS32-3F-10)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  277. ESi038-C (CBiPS32-3F-12)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  278. ESi040-A ([PD] FiPS006-4F-11)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Parkinson's disease

  279. ESi041-A (CBiPS 2F-1c)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  280. ESi041-B (CBiPS 4F-3a)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  281. ESi041-C (CBiPS 4F 10b)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  282. ESi042-A ([TSD] FiPS-4F-3-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Tay-sachs disease

  283. ESi043-A ([ctrl.PD] FiPS005-4F-9)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  284. ESi044-A (FiPS Ctrl1-mR5F-6)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  285. ESi044-B (FiPS Ctrl1-Ep6F-5)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  286. ESi044-C (FiPS Ctrl1-SV4F-7)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  287. ESi044-D (FiPS Ctrl1-R4F-4)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  288. ESi045-A (FiPS Ctrl2-mR5F-6)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  289. ESi045-B (FiPS Ctrl2-Ep6F-8)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  290. ESi045-C (FiPS Ctrl2-SV4F-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  291. ESi045-D (FiPS Ctrl2-R4F-5)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  292. ESi046-A ([UCiPS] Ctrl5-R4F-25)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  293. ESi048-A (MS FiPS 1-R4F-3)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Multiple sclerosis

  294. ESi049-A (MS FiPS 2 R4F-10)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Multiple sclerosis

  295. ESi050-A (MS FiPS 3-R4F-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Multiple sclerosis

  296. ESi051-A (MS FiPS 4-R4F-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Multiple sclerosis

  297. ESi052-A (MS FiPS 5-R4F-6)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Multiple sclerosis

  298. ESi053-A (MS FiPS 6-R4F-2)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Multiple sclerosis

  299. ESi054-A (AS FiPS 1-Ep6F-2)

    Spain Spanish Stem Cell Bank (ES)

  300. ESi055-A (AS FiPS 2-Ep6F-28)

    Spain Spanish Stem Cell Bank (ES)

  301. ESi056-A (AS FiPS 3-Ep6F-9)

    Spain Spanish Stem Cell Bank (ES)

  302. ESi057-A ([DUP7] FiPS-4F-3-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Autism

  303. ESi057-B ([DUPSW] FiPS301-R4F-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Autism

  304. ESi058-A ([DUP7] FiPS-4F-4-6)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Autism

  305. ESi058-B ([DUP7] FiPS4-R4F-2)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Autism

  306. ESi059-A ([SWB] FiPS-4F-1-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Williams syndrome

  307. ESi059-B ([SWB] FiPS1-R4F-5)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Williams syndrome

  308. ESi060-A ([SWB] FiPS-4F-5-6)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Williams syndrome

  309. ESi060-B ([SWB] FiPS5-R4F-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Williams syndrome

  310. ESi065-A ([IDDM1] FiPS 1.13-Ep6F-9)

    Spain Spanish Stem Cell Bank (ES)

  311. ESe009-A (ES-2)

    Spain Spanish Stem Cell Bank (ES)

  312. ESe010-A (ES-3)

    Spain Spanish Stem Cell Bank (ES)

  313. ESe011-A (VAL-3)

    Spain Spanish Stem Cell Bank (ES)

  314. ESe012-A (VAL-4)

    Spain Spanish Stem Cell Bank (ES)

  315. ESe013-A (VAL-5)

    Spain Spanish Stem Cell Bank (ES)

  316. ESe014-A (ES-4 and ES[4])

    Spain Spanish Stem Cell Bank (ES)

  317. ESe015-A (ES-6)

    Spain Spanish Stem Cell Bank (ES)

  318. ESe016-A (ES-5)

    Spain Spanish Stem Cell Bank (ES)

  319. ESe017-A (VAL-6M)

    Spain Spanish Stem Cell Bank (ES)

  320. ESe018-A (VAL-7)

    Spain Spanish Stem Cell Bank (ES)

  321. ESe019-A (VAL-9)

    Spain Spanish Stem Cell Bank (ES)

  322. ESe020-A (VAL-10B)

    Spain Spanish Stem Cell Bank (ES)

  323. ESe021-A (VAL-8)

    Spain Spanish Stem Cell Bank (ES)

  324. ESe022-A (ES-7)

    Spain Spanish Stem Cell Bank (ES)

  325. ESe023-A (ES-8)

    Spain Spanish Stem Cell Bank (ES)

  326. ESe024-A (ES-9)

    Spain Spanish Stem Cell Bank (ES)

  327. ESe025-A (ES-10)

    Spain Spanish Stem Cell Bank (ES)

  328. ESe026-A (ES-11EM)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Hereditary multiple exostoses

  329. ESe027-A (pES12)

    Spain Spanish Stem Cell Bank (ES)

  330. ESe028-A (bES[13])

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  331. ESe029-A (AND-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (normalities, health, normalcy, normality)

  332. ESIBIe001-A (HES-1)

    Singapore ES Cell International Pte Ltd. (ESIBI)

  333. ESIBIe002-A (HES-2)

    Singapore ES Cell International Pte Ltd. (ESIBI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  334. ESIBIe003-A (HES-3 and hES 3)

    Singapore ES Cell International Pte Ltd. (ESIBI)

  335. ESIBIe003-A-1 (hES3.1)

    Australia ES Cell International Pte Ltd. (ESIBI)

  336. ESIBIe003-A-2 (hES3.2)

    Australia ES Cell International Pte Ltd. (ESIBI)

  337. ESIBIe003-A-3 (hES3.3)

    Australia ES Cell International Pte Ltd. (ESIBI)

  338. ESIBIe004-A (HES-4)

    Singapore ES Cell International Pte Ltd. (ESIBI)

  339. ESIBIe005-A (HES-5)

    Singapore ES Cell International Pte Ltd. (ESIBI)

  340. ESIBIe006-A (HES-6)

    Singapore ES Cell International Pte Ltd. (ESIBI)

  341. EVMSe001-A (ES-76)

    United States Eastern Virginia Medical School (EVMS)

  342. EVMSe002-A (ES-78-1)

    United States Eastern Virginia Medical School (EVMS)

  343. EVMSe003-A (ES-78-2)

    United States Eastern Virginia Medical School (EVMS)

  344. FAMRCi001-A (ARVC2)

    Russia Federal Almazov North-West Medical Research Centre (FAMRC)
    Disease:

    Arrhythmogenic right ventricular cardiomyopathy

  345. FAMRCi001-B (ARVC4)

    Russia Federal Almazov North-West Medical Research Centre (FAMRC)
    Disease:

    Arrhythmogenic right ventricular cardiomyopathy

  346. FAMRCi002-A (OBC7)

    Russia Federal Almazov North-West Medical Research Centre (FAMRC)
    Disease:

    Desminopathy

  347. FAMRCi003-A (108-1)

    Russia Federal Almazov North-West Medical Research Centre (FAMRC)
    Disease:

    Normal (normalities, health, normalcy, normality)

  348. FAMRCi003-B (108-2)

    Russia Federal Almazov North-West Medical Research Centre (FAMRC)
    Disease:

    Normal (normalities, health, normalcy, normality)

  349. FJMUi001-A (hiPS-SPG76-001)

    China Fujian Medical University (FJMU)
    Disease:

    Hereditary spastic paraplegia

  350. GENEAe001-A (GENEA001 and SIVF01)

    Australia Genea (GENEA)
    Disease:

    Normal (normalities, health, normalcy, normality)

  351. GENEAe002-A (GENEA003 and SIVF03)

    Australia Genea (GENEA)

  352. GENEAe003-A (SIVF04 and GENEA004)

    Australia Genea (GENEA)

  353. GENEAe004-A (SIVF05 and GENEA005)

    Australia Genea (GENEA)

  354. GENEAe005-A (SIVF06 and GENEA006)

    Australia Genea (GENEA)

  355. GENEAe006-A (SIVF07 and GENEA007)

    Australia Genea (GENEA)

  356. GENEAe007-A (GENEA008 and SIVF08)

    Australia Genea (GENEA)

  357. GENEAe008-A (GENEA009 and SIVF09)

    Australia Genea (GENEA)

  358. GENEAe009-A (SIVF10 and GENEA010)

    Australia Genea (GENEA)

  359. GENEAe010-A (SIVF11 and GENEA011)

    Australia Genea (GENEA)

  360. GENEAe011-A (SIVF12 and GENEA012)

    Australia Genea (GENEA)

  361. GENEAe012-A (SIVF13 and GENEA013)

    Australia Genea (GENEA)

  362. GENEAe013-A (GENEA089)

    Australia Genea (GENEA)
    Disease:

    Huntington disease

  363. GENEAe014-A (GENEA029)

    United States Genea (GENEA)
    Disease:

    Normal (normalities, health, normalcy, normality)

  364. GENEAe015-A (GENEA020)

    United States Genea (GENEA)
    Disease:

    Huntington disease

  365. GENEAe016-A (GENEA022)

    Australia Genea (GENEA)
    Disease:

    Normal (normalities, health, normalcy, normality)

  366. GENEAe017-A (GENEA023)

    Australia Genea (GENEA)
    Disease:

    Normal (normalities, health, normalcy, normality)

  367. GENEAe018-A (GENEA090)

    Australia Genea (GENEA)
    Disease:

    Huntington disease

  368. GENEAe019-A (GENEA091)

    Australia Genea (GENEA)
    Disease:

    Huntington disease

  369. GENEAe020-A (GENEA019)

    Australia Genea (GENEA)
    Disease:

    Normal (normalities, health, normalcy, normality)

  370. GENEAe021-A (GENEA021)

    Australia Genea (GENEA)
    Disease:

    Normal (normalities, health, normalcy, normality)

  371. GENYOi004-A (ASD-PBMC-iPS4F2)

    Spain Centre for Genomics and Oncological Research (GENYO)
    Disease:

    Adnp syndrome

  372. GUCASe001-A (hPES-1)

    China Graduate University of Chinese Academy of Sciences (GUCAS)

  373. GUCASe002-A (hPES-2)

    China Graduate University of Chinese Academy of Sciences (GUCAS)

  374. GZHMCe001-A (FY-hES-5)

    China The Third Affiliated Hospital of Guangzhou Medical College (GZHMC)
    Disease:

    Patau syndrome

  375. GZHMCe002-A (FY-hES-9)

    China The Third Affiliated Hospital of Guangzhou Medical College (GZHMC)

  376. GZHMCe003-A (FY-hES-10)

    China The Third Affiliated Hospital of Guangzhou Medical College (GZHMC)

  377. GZHMCe004-A (FY-hES-11)

    China The Third Affiliated Hospital of Guangzhou Medical College (GZHMC)

  378. HADe001-A (HAD 1)

    Israel Hadassah University Hospital (HAD)
    Disease:

    Myotonic dystrophy type 1

  379. HADe002-A (HAD 2)

    Israel Hadassah University Hospital (HAD)
    Disease:

    Cystic fibrosis

  380. HADe003-A (HAD 3)

    Israel Hadassah University Hospital (HAD)
    Disease:

    Factor viii deficiency

  381. HADe004-A (HAD 4)

    Israel Hadassah University Hospital (HAD)

  382. HADe005-A (HAD 5)

    Israel Hadassah University Hospital (HAD)
    Disease:

    Fragile x syndrome

  383. HADe006-A (HAD 6)

    Israel Hadassah University Hospital (HAD)

  384. HADe007-A (HAD-C 100)

    Israel Hadassah University Hospital (HAD)
    Disease:

    Normal (normalities, health, normalcy, normality)

  385. HADe008-A (HAD-C 102)

    Israel Hadassah University Hospital (HAD)
    Disease:

    Normal (normalities, health, normalcy, normality)

  386. HADe009-A (HAD-C 106)

    Israel Hadassah University Hospital (HAD)
    Disease:

    Normal (normalities, health, normalcy, normality)

  387. HEBHMUi001-A

    China Hebei Medical University (HEBHMU)
    Disease:

    Parkinson's disease

  388. HMGUi001-A (XM001)

    Germany Helmholtz Zentrum München (HMGU)
    Disease:

    Normal (normalities, health, normalcy, normality)

  389. HMGUi001-A-1 (hINS-T2A-H2B-Cherry (+/-) and HMGUi001-A-1)

    Germany Helmholtz Zentrum München (HMGU)
    Disease:

    Normal (normalities, health, normalcy, normality)

  390. HUBi001-A (HUB001Ai)

    Netherlands The Hubrecht Institute (HUB)
    Disease:

    Normal (normalities, health, normalcy, normality)

  391. HUJIe001-A (HEFX1)

    Israel Hebrew University of Jerusalem (HUJI)
    Disease:

    Fragile x syndrome

  392. HUSTe001-A (hES-8)

    China Huazhong University of Science and Technology (HUST)

  393. HUSTe002-A (hES-18)

    China Huazhong University of Science and Technology (HUST)

  394. HVRDi004-B (GM23338)

    United States Harvard University (HVRD)
    Disease:

    Normal (normalities, health, normalcy, normality)

  395. HVRDi004-B-1 (ENCBS369AAA and iNGN)

    United States Harvard University (HVRD)
    Disease:

    Normal (normalities, health, normalcy, normality)

  396. HVRDi005-A (BJ SiPS-D)

    United States Harvard University (HVRD)
    Disease:

    Normal (normalities, health, normalcy, normality)

  397. HVRDi006-A (18b healthy control)

    United States Harvard University (HVRD)
    Disease:

    Normal (normalities, health, normalcy, normality)

  398. HVRDi007-A (DiPS 1016SevA)

    United States Harvard University (HVRD)
    Disease:

    Normal (normalities, health, normalcy, normality)

  399. HVRDi008-A (SOD1-27e)

    United States Harvard University (HVRD)
    Disease:

    Amyotrophic lateral sclerosis

  400. HVRDi009-A (29e SOD1 L144F)

    United States Harvard University (HVRD)
    Disease:

    Amyotrophic lateral sclerosis

  401. HVRDi010-A (C9orf72-19A)

    United States Harvard University (HVRD)
    Disease:

    Amyotrophic lateral sclerosis

  402. HVRDe001-A (HuES1)

    United States Harvard University (HVRD)

  403. HVRDe001-A-1

    United States Harvard University (HVRD)

  404. HVRDe002-A (HuES2)

    United States Harvard University (HVRD)

  405. HVRDe003-A (HuES3)

    United States Harvard University (HVRD)

  406. HVRDe004-A (HuES4)

    United States Harvard University (HVRD)

  407. HVRDe005-A (HuES5)

    United States Harvard University (HVRD)

  408. HVRDe006-A (HuES6)

    United States Harvard University (HVRD)

  409. HVRDe007-A (HuES7)

    United States Harvard University (HVRD)

  410. HVRDe008-A (HuES8)

    United States Harvard University (HVRD)

  411. HVRDe009-A (HuES9)

    United States Harvard University (HVRD)

  412. HVRDe010-A (HuES10)

    United States Harvard University (HVRD)

  413. HVRDe011-A (HuES11)

    United States Harvard University (HVRD)

  414. HVRDe012-A (HuES12)

    United States Harvard University (HVRD)

  415. HVRDe013-A (HuES13)

    United States Harvard University (HVRD)

  416. HVRDe014-A (HuES14)

    United States Harvard University (HVRD)

  417. HVRDe015-A (HuES15)

    United States Harvard University (HVRD)

  418. HVRDe016-A (HuES16)

    United States Harvard University (HVRD)

  419. HVRDe017-A (HuES17)

    United States Harvard University (HVRD)

  420. IAIi001-A (IAIi001RSTS2-65-A)

    Italy Istituto Auxologico Italiano IRCCS (IAI)
    Disease:

    Rubinstein-taybi syndrome

  421. IAIi002-A (IAIi002RSTS1-34-A)

    Italy Istituto Auxologico Italiano IRCCS (IAI)
    Disease:

    Rubinstein-taybi syndrome

  422. IAIi003-A (IAIi003RSTS1-46-A)

    Italy Istituto Auxologico Italiano IRCCS (IAI)
    Disease:

    Rubinstein-taybi syndrome

  423. IAIi004-A (IAIi004RSTS1-149-A)

    Italy Istituto Auxologico Italiano IRCCS (IAI)
    Disease:

    Rubinstein-taybi syndrome

  424. IBMSi001-A (IBMS-iPSC-012-12)

    Taiwan Institute of Biomedical Sciences, Academia Sinica (IBMS)
    Disease:

    Autosomal dominant polycystic kidney disease

  425. IBMSi002-A (IBMS-iPSC-013-06)

    Taiwan Institute of Biomedical Sciences, Academia Sinica (IBMS)
    Disease:

    Autosomal dominant polycystic kidney disease

  426. IBMSi003-A (IBMS-iPSC-014-05)

    Taiwan Institute of Biomedical Sciences, Academia Sinica (IBMS)
    Disease:

    Autosomal dominant polycystic kidney disease

  427. IBPi001-A (HPrF iPSCs 20A)

    Czech Republic Institute of Biophysics of the Czech Academy of Sciences (IBP)
    Disease:

    Normal (normalities, health, normalcy, normality)

  428. IBPi002-A (P71 iPSCs 1)

    Czech Republic Institute of Biophysics of the Czech Academy of Sciences (IBP)
    Disease:

    Prostate adenocarcinoma

  429. ICAGi001-A (iTaf9-11)

    Russia THE FEDERAL RESEARCH CENTER INSTITUTE OF CYTOLOGY AND GENETICS (ICAG)

  430. ICGi005-A (iSMA40)

    Russia The Federal Research Center Institute of Cytology and Genetics The Siberian Branch of the Russian Academy of Sciences (ICG)
    Disease:

    Proximal spinal muscular atrophy type 1

  431. ICGi005-B (iSMA37)

    Russia The Federal Research Center Institute of Cytology and Genetics The Siberian Branch of the Russian Academy of Sciences (ICG)
    Disease:

    Proximal spinal muscular atrophy type 1

  432. ICGi006-A (m3SMA13)

    Russia The Federal Research Center Institute of Cytology and Genetics The Siberian Branch of the Russian Academy of Sciences (ICG)
    Disease:

    Proximal spinal muscular atrophy type 2

  433. ICGi006-B (m3SMA20)

    Russia The Federal Research Center Institute of Cytology and Genetics The Siberian Branch of the Russian Academy of Sciences (ICG)
    Disease:

    Proximal spinal muscular atrophy type 2

  434. ICGi007-A (47Q-3Lf)

    Russia The Federal Research Center Institute of Cytology and Genetics The Siberian Branch of the Russian Academy of Sciences (ICG)
    Disease:

    Huntington disease

  435. ICGi008-A (m55Alz-9L)

    Russia The Federal Research Center Institute of Cytology and Genetics The Siberian Branch of the Russian Academy of Sciences (ICG)
    Disease:

    Alzheimer's disease

  436. ICGi008-B (m55Alz-15L)

    Russia The Federal Research Center Institute of Cytology and Genetics The Siberian Branch of the Russian Academy of Sciences (ICG)
    Disease:

    Alzheimer's disease

  437. IDISi001-A

    Spain Health Research Institute of Santiago de Compostela (IDIS)
    Disease:

    Cadasil

  438. IDVi001-A (iPS-NR2E3-86)

    France INSTITUT DE LA VISION (IDV)
    Disease:

    Retinitis pigmentosa

  439. IDVi002-A (iPS-PRPF31-4138)

    France INSTITUT DE LA VISION (IDV)
    Disease:

    Normal (normalities, health, normalcy, normality)

  440. TECHe001-A (I3)

    Israel Technion - Israel Institute of Technology (IIT)

  441. TECHe001-A-1 (I3.2)

    Israel Technion - Israel Institute of Technology (IIT)

  442. TECHe001-A-2 (I3.3)

    Israel Technion - Israel Institute of Technology (IIT)

  443. TECHe002-A (I4)

    Israel Technion - Israel Institute of Technology (IIT)

  444. TECHe003-A (I6)

    Israel Technion - Israel Institute of Technology (IIT)

  445. TECHe003-A-1 (I6.2)

    Israel Technion - Israel Institute of Technology (IIT)

  446. TECHe004-A (J3)

    Israel Technion - Israel Institute of Technology (IIT)

  447. TECHe004-A-1 (J3.2)

    Israel Technion - Israel Institute of Technology (IIT)

  448. IMGTi001-A (iTAF5-29)

    Russia Research Institute of Medical Genetics, TNMRC (IMGT)
    Disease:

    Monosomy 22q13

  449. IMGTi001-B (iTAF5-32)

    Russia Research Institute of Medical Genetics, TNMRC (IMGT)
    Disease:

    Monosomy 22q13

  450. IMGTi003-A (iTAF6-6)

    Russia Research Institute of Medical Genetics, TNMRC (IMGT)

  451. IMHe001-A (NS-3)

    Turkey ISTANBUL MEMORIAL HOSPITAL (IMH)

  452. IMHe002-A (NS-4)

    Turkey ISTANBUL MEMORIAL HOSPITAL (IMH)

  453. IMHe003-A (NS-5)

    Turkey ISTANBUL MEMORIAL HOSPITAL (IMH)

  454. IMHe004-A (NS-6)

    Turkey ISTANBUL MEMORIAL HOSPITAL (IMH)

  455. IMHe005-A (NS-7)

    Turkey ISTANBUL MEMORIAL HOSPITAL (IMH)

  456. IMHe006-A (NS-8)

    Turkey ISTANBUL MEMORIAL HOSPITAL (IMH)

  457. IMHe007-A (MINE)

    Turkey ISTANBUL MEMORIAL HOSPITAL (IMH)

  458. IMHe008-A (OZ)

    Turkey ISTANBUL MEMORIAL HOSPITAL (IMH)
    Disease:

    Chromosomal disease

  459. IMHe009-A (OZ-1)

    Turkey ISTANBUL MEMORIAL HOSPITAL (IMH)
    Disease:

    Chromosomal disease

  460. IMHe010-A (OZ-2)

    Turkey ISTANBUL MEMORIAL HOSPITAL (IMH)

  461. IMHe011-A (OZ-8)

    Turkey ISTANBUL MEMORIAL HOSPITAL (IMH)
    Disease:

    Beta thalassemia

  462. IMHe012-A (NS-9)

    Turkey ISTANBUL MEMORIAL HOSPITAL (IMH)

  463. IMHe013-A (NS-10)

    Turkey ISTANBUL MEMORIAL HOSPITAL (IMH)

  464. IMHe014-A (OZ-3)

    Turkey ISTANBUL MEMORIAL HOSPITAL (IMH)

  465. IMHe015-A (OZ-4)

    Turkey ISTANBUL MEMORIAL HOSPITAL (IMH)

  466. IMHe016-A (OZ-5)

    Turkey ISTANBUL MEMORIAL HOSPITAL (IMH)

  467. IMHe017-A (OZ-6)

    Turkey ISTANBUL MEMORIAL HOSPITAL (IMH)

  468. IMHe018-A (OZ-7)

    Turkey ISTANBUL MEMORIAL HOSPITAL (IMH)

  469. INSRMe001-A (OSCAR)

    France INSERM (INSRM)
    Disease:

    Normal (normalities, health, normalcy, normality)

  470. INSRMe002-A (STR-I-233-FRAXA)

    France INSERM (INSRM)
    Disease:

    Fragile x syndrome

  471. INSRMe003-A (STR-I-155-HD)

    France INSERM (INSRM)
    Disease:

    Huntington disease

  472. INSRMe004-A (STR-I-171-GLA)

    France INSERM (INSRM)
    Disease:

    Fabry disease

  473. INSRMe005-A (STR-I-189-FRAXA)

    France INSERM (INSRM)
    Disease:

    Fragile x syndrome

  474. INSRMe006-A (STR-I-209-MEN2a)

    France INSERM (INSRM)
    Disease:

    Endocrine gland cancer

  475. INSRMe007-A (STR-I-211-MEN2a)

    France INSERM (INSRM)
    Disease:

    Endocrine gland cancer

  476. INSRMe008-A (STR-I-203-CFTR)

    France INSERM (INSRM)
    Disease:

    Cystic fibrosis

  477. INSRMe009-A (STR-I-251-CFTR)

    France INSERM (INSRM)
    Disease:

    Cystic fibrosis

  478. INSRMe010-A (STR-I-221-Sca2)

    France INSERM (INSRM)
    Disease:

    Autosomal dominant cerebellar ataxia

  479. INSRMe011-A (STR-I-229-MTMX)

    France INSERM (INSRM)
    Disease:

    X-linked myopathy with excessive autophagy

  480. INSRMe012-A (STR-I-231-MTMX)

    France INSERM (INSRM)
    Disease:

    X-linked myopathy with excessive autophagy

  481. INSRMe013-A (STR-I-301-MFS)

    France INSERM (INSRM)
    Disease:

    Marfan syndrome

  482. INSRMe014-A (STR-I-305-APC)

    France INSERM (INSRM)
    Disease:

    Familial adenomatous polyposis

  483. INSRMe015-A (STR-I-315-CMT1a)

    France INSERM (INSRM)
    Disease:

    Charcot-marie-tooth disease type 1

  484. INSRMe016-A (STR-I-347-FRAXA)

    France INSERM (INSRM)
    Disease:

    Fragile x syndrome

  485. INSRMe017-A (STR-I-355-APC)

    France INSERM (INSRM)
    Disease:

    Familial adenomatous polyposis

  486. INSRMe018-A (STR-I-359-APC)

    France INSERM (INSRM)
    Disease:

    Familial adenomatous polyposis

  487. IRFMNi001-A (iPS clone IV)

    Italy IRCCS - Istituto di Ricerche Farmacologiche Mario Negri (IRFMN)
    Disease:

    Normal (normalities, health, normalcy, normality)

  488. IRFMNi002-A (PRM#14)

    Italy IRCCS - Istituto di Ricerche Farmacologiche Mario Negri (IRFMN)
    Disease:

    Focal segmental glomerulosclerosis

  489. IRFMNi002-B (PRM#18)

    Italy IRCCS - Istituto di Ricerche Farmacologiche Mario Negri (IRFMN)
    Disease:

    Focal segmental glomerulosclerosis

  490. IRMBi001-A (AD-PS1 hiPSC)

    France Institute for Regenerative Medecine and Biotherapy (IRMB)
    Disease:

    Alzheimer's disease

  491. IRMBi002-A (AD-APP hiPSC)

    France Institute for Regenerative Medecine and Biotherapy (IRMB)
    Disease:

    Alzheimer's disease

  492. ISMMSi001-A (SAMEA104275576 and MFS44-E)

    United States Icahn School of Medicine at Mount Sinai (ISMMS)
    Disease:

    Marfan syndrome

  493. ISMMSi001-B (SAMEA104275577 and MFS44-16)

    United States Icahn School of Medicine at Mount Sinai (ISMMS)
    Disease:

    Marfan syndrome

  494. ISMMSi002-A (SAMEA104275578 and MFS60-12)

    United States Icahn School of Medicine at Mount Sinai (ISMMS)
    Disease:

    Marfan syndrome

  495. ISMMSi002-B (MFS60-3-1 and SAMEA104276575)

    United States Icahn School of Medicine at Mount Sinai (ISMMS)
    Disease:

    Marfan syndrome

  496. ITSe001-A (NT-hESC)

    India Civil Hospital Campus (ITS)

  497. JNCSRe001-A (BJNhem19)

    India Jawaharlal Nehru Centre for Advanced Scientific Research (JNCSR)

  498. JNCSRe002-A (BJNhem20)

    India Jawaharlal Nehru Centre for Advanced Scientific Research (JNCSR)

  499. KCLi001-A (iOP118)

    United Kingdom King's College London (KCL)
    Disease:

    Atopic eczema

  500. KCLi002-A (iOP107)

    United Kingdom King's College London (KCL)
    Disease:

    Atopic eczema

  501. KCLi003-A (iOP101)

    United Kingdom King's College London (KCL)
    Disease:

    Atopic eczema

  502. KCLe001-A (KCL-001 (WT-3))

    United Kingdom King's College London (KCL)

  503. KCLe002-A (KCL-002 (WT-4))

    United Kingdom King's College London (KCL)

  504. KCLe003-A (KCL-003-CF-1)

    United Kingdom King's College London (KCL)
    Disease:

    Cystic fibrosis

  505. KCLe004-A (KCL-005_HD1)

    United Kingdom King's College London (KCL)
    Disease:

    Monogenic disease

  506. KCLe005-A (KCL004)

    United Kingdom King's College London (KCL)

  507. KCLe006-A (KCL006)

    United Kingdom King's College London (KCL)

  508. KCLe007-A (KCL008_HD2)

    United Kingdom King's College London (KCL)
    Disease:

    Klinefelter's syndrome

  509. KCLe008-A (KCL009_trans1)

    United Kingdom King's College London (KCL)
    Disease:

    Chromosomal disease

  510. KCLe009-A (KCL012_HD3)

    United Kingdom King's College London (KCL)
    Disease:

    Huntington disease

  511. KCLe010-A (KCL013_HD4)

    United Kingdom King's College London (KCL)
    Disease:

    Huntington disease

  512. KCLe011-A (KCL015_VHL2)

    United Kingdom King's College London (KCL)
    Disease:

    Von hippel-lindau disease

  513. KCLe012-A (KCL016_VHL3)

    United Kingdom King's College London (KCL)
    Disease:

    Von hippel-lindau disease

  514. KCLe013-A (KCL017_VHL4)

    United Kingdom King's College London (KCL)
    Disease:

    Von hippel-lindau disease

  515. KCLe014-A (KCL018_MD1)

    United Kingdom King's College London (KCL)
    Disease:

    Myotonic dystrophy type 1

  516. KCLe015-A (KCL011)

    United Kingdom King's College London (KCL)

  517. KGUi001-A (AR1023)

    Germany Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, University Hospital, Goethe University of Frankfurt/Main (KGU)
    Disease:

    Bipolar disorder

  518. KGUi002-A (AR1034)

    Germany Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, University Hospital, Goethe University of Frankfurt/Main (KGU)
    Disease:

    Bipolar disorder

  519. KIe001-A (HS181)

    Sweden Karolinska Institutet (KI)

  520. KIe001-A-1

    Sweden Karolinska Institutet (KI)

  521. KIe002-A (HS207)

    Sweden Karolinska Institutet (KI)

  522. KIe003-A (HS235)

    Sweden Karolinska Institutet (KI)

  523. KIe004-A (HS237)

    Sweden Karolinska Institutet (KI)

  524. KIe004-A-1

    Sweden Karolinska Institutet (KI)

  525. KIe005-A (HS293)

    Sweden Karolinska Institutet (KI)

  526. KIe006-A (HS306)

    Sweden Karolinska Institutet (KI)

  527. KIe006-A-1

    Sweden Karolinska Institutet (KI)

  528. KIe007-A (HS346)

    Sweden Karolinska Institutet (KI)

  529. KIe007-A-1

    Sweden Karolinska Institutet (KI)

  530. KIe008-A (HS351)

    Sweden Karolinska Institutet (KI)

  531. KIe008-A-1

    Sweden Karolinska Institutet (KI)

  532. KIe009-A (HS360)

    Sweden Karolinska Institutet (KI)

  533. KIe009-A-1

    Sweden Karolinska Institutet (KI)

  534. KIe010-A (HS361)

    Sweden Karolinska Institutet (KI)

  535. KIe010-A-1

    Sweden Karolinska Institutet (KI)

  536. KIe011-A (HS362)

    Sweden Karolinska Institutet (KI)

  537. KIe011-A-1

    Sweden Karolinska Institutet (KI)

  538. KIe012-A (HS363)

    Sweden Karolinska Institutet (KI)

  539. KIe012-A-1

    Sweden Karolinska Institutet (KI)

  540. KIe013-A (HS364)

    Sweden Karolinska Institutet (KI)

  541. KIe013-A-1

    Sweden Karolinska Institutet (KI)

  542. KIe014-A (HS366)

    Sweden Karolinska Institutet (KI)

  543. KIe014-A-1

    Sweden Karolinska Institutet (KI)

  544. KIe015-A (HS368)

    Sweden Karolinska Institutet (KI)

  545. KIe015-A-1

    Sweden Karolinska Institutet (KI)

  546. KIe016-A (HS380)

    Sweden Karolinska Institutet (KI)

  547. KIe016-A-1

    Sweden Karolinska Institutet (KI)

  548. KIe017-A (HS382)

    Sweden Karolinska Institutet (KI)

  549. KIe017-A-1

    Sweden Karolinska Institutet (KI)

  550. KIe018-A (HS400)

    Sweden Karolinska Institutet (KI)

  551. KIe018-A-1

    Sweden Karolinska Institutet (KI)

  552. KIe019-A (HS401)

    Sweden Karolinska Institutet (KI)

  553. KIe019-A-1

    Sweden Karolinska Institutet (KI)

  554. KIe020-A (HS402)

    Sweden Karolinska Institutet (KI)

  555. KIe020-A-1

    Sweden Karolinska Institutet (KI)

  556. KIe021-A (HS415)

    Sweden Karolinska Institutet (KI)

  557. KIe021-A-1

    Sweden Karolinska Institutet (KI)

  558. KIe022-A (HS420)

    Sweden Karolinska Institutet (KI)

  559. KIe022-A-1

    Sweden Karolinska Institutet (KI)

  560. KIe023-A (HS426)

    Sweden Karolinska Institutet (KI)

  561. KIe024-A (HS429)

    Sweden Karolinska Institutet (KI)

  562. KIe024-A-1 (HS429A)

    Sweden Karolinska Institutet (KI)

  563. KIe024-A-2 (HS429B)

    Sweden Karolinska Institutet (KI)

  564. KIe024-A-3 (HS429C)

    Sweden Karolinska Institutet (KI)

  565. KIe024-A-4 (HS429D)

    Sweden Karolinska Institutet (KI)

  566. KIe025-A (HS475)

    Sweden Karolinska Institutet (KI)

  567. KIe026-A (HS480)

    Sweden Karolinska Institutet (KI)

  568. KIe027-A (HS481)

    Sweden Karolinska Institutet (KI)

  569. KIe028-A (HS491)

    Sweden Karolinska Institutet (KI)

  570. KIe029-A (HS422)

    Sweden Karolinska Institutet (KI)

  571. KIe030-A (HS356)

    Sweden Karolinska Institutet (KI)

  572. KIe031-A (HS539)

    Sweden Karolinska Institutet (KI)

  573. KIe032-A (HS975)

    Sweden Karolinska Institutet (KI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  574. KIe033-A (HS980)

    Sweden Karolinska Institutet (KI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  575. KLRMMEi001-A

    China Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University. (KLRMME)
    Disease:

    Retinitis pigmentosa

  576. KMUe001-A (T1)

    Taiwan Kaohsiung Medical University (KMU)

  577. KMUe002-A (T2)

    Taiwan Kaohsiung Medical University (KMU)

  578. KMUe003-A (T3)

    Taiwan Kaohsiung Medical University (KMU)

  579. KMUe004-A (T4)

    Taiwan Kaohsiung Medical University (KMU)

  580. KMUe005-A (T5)

    Taiwan Kaohsiung Medical University (KMU)

  581. KSCBi001-A (hUSiPS2)

    South Korea National Stem Cell Bank (KSCB)
    Disease:

    Normal (normalities, health, normalcy, normality)

  582. KSCBi002-A (hFSiPS1)

    South Korea National Stem Cell Bank (KSCB)
    Disease:

    Normal (normalities, health, normalcy, normality)

  583. KSCBi002-B (hFmiPS1)

    South Korea National Stem Cell Bank (KSCB)
    Disease:

    Normal (normalities, health, normalcy, normality)

  584. KSCBi002-B-1 (hFmiPS2)

    South Korea National Stem Cell Bank (KSCB)
    Disease:

    Normal (normalities, health, normalcy, normality)

  585. KSCBi003-A (hAdMSiPS1)

    South Korea National Stem Cell Bank (KSCB)
    Disease:

    Normal (normalities, health, normalcy, normality)

  586. KSCBi005-A (CMC-hiPSC-003)

    South Korea National Stem Cell Bank (KSCB)
    Disease:

    Normal (normalities, health, normalcy, normality)

  587. KSCBi005-A-1 (CMC-hiPSC-003(Nestin-GFP) and CMC-003i-Nestin.EGFP)

    South Korea National Stem Cell Bank (KSCB)
    Disease:

    Normal (normalities, health, normalcy, normality)

  588. KUe001-A (LRB001)

    Denmark University of Copenhagen (KU)

  589. KUe002-A (LRB02)

    Denmark University of Copenhagen (KU)

  590. KUe003-A (LRB03)

    Denmark University of Copenhagen (KU)

  591. KUe004-A (LRB04)

    Denmark University of Copenhagen (KU)

  592. KUe005-A (LRB05)

    Denmark University of Copenhagen (KU)

  593. KUe006-A (LRB06)

    Denmark University of Copenhagen (KU)

  594. KUe007-A (LRB07)

    Denmark University of Copenhagen (KU)

  595. KUe008-A (LRB08)

    Denmark University of Copenhagen (KU)

  596. KUe009-A (LRB09)

    Denmark University of Copenhagen (KU)

  597. KUe010-A (LRB011)

    Denmark University of Copenhagen (KU)

  598. KUe011-A (LRB013)

    Denmark University of Copenhagen (KU)

  599. KUe012-A (LRB014)

    Denmark University of Copenhagen (KU)

  600. KUe013-A (LRB016)

    Denmark University of Copenhagen (KU)

  601. KUe014-A (LRB017)

    Denmark University of Copenhagen (KU)

  602. KUe015-A (LRB018)

    Denmark University of Copenhagen (KU)

  603. KUIFMSi004-A (201B1)

    Japan Kyoto University (KUIMS)

  604. KUIFMSi004-B (201B6)

    Japan Kyoto University (KUIMS)

  605. KUIFMSi004-C (201B7)

    Japan Kyoto University (KUIMS)

  606. KUIFMSi004-D (201B2)

    Japan Kyoto University (KUIMS)

  607. KUIFMSi004-E (201B3)

    Japan Kyoto University (KUIMS)

  608. KUIFMSi009-A (243H1)

    Japan Kyoto University (KUIMS)

  609. KUIFMSi009-B (243H7)

    Japan Kyoto University (KUIMS)

  610. KUIFMSi011-A (246G1)

    Japan Kyoto University (KUIMS)

  611. KUIFMSi011-B (246G3)

    Japan Kyoto University (KUIMS)

  612. KUIFMSi011-C (246G4)

    Japan Kyoto University (KUIMS)

  613. KUIFMSi011-D (246G5)

    Japan Kyoto University (KUIMS)

  614. KUIFMSi011-E (246G6)

    Japan Kyoto University (KUIMS)

  615. KUIMSe001-A (KhES-1)

    Japan Kyoto University (KUIMS)

  616. KUIMSe002-A (KhES-2)

    Japan Kyoto University (KUIMS)

  617. KUIMSe003-A (KhES-3)

    Japan Kyoto University (KUIMS)

  618. KUIMSe003-A-1

    Japan Kyoto University (KUIMS)

  619. LEIi004-A

    Australia Lions Eye Institute (LEI)
    Disease:

    Retinitis pigmentosa

  620. LEIi004-A-1

    Australia Lions Eye Institute (LEI)
    Disease:

    Retinitis pigmentosa

  621. LEIi005-A

    Australia Lions Eye Institute (LEI)
    Disease:

    Retinitis pigmentosa

  622. LEIi006-A

    Australia Lions Eye Institute (LEI)
    Disease:

    Retinitis pigmentosa

  623. LUBi001-A (PGRN-8310, PGRN8310, RCi195 and RCFB58 c12.5)

    Denmark H. Lundbeck A/S (LUB)
    Disease:

    Frontotemporal dementia

  624. LUBi001-B (PGRN-8310, RCFB58 c4.4, PGRN8310 and RCi194)

    Denmark H. Lundbeck A/S (LUB)
    Disease:

    Frontotemporal dementia

  625. LUBi001-C (PGRN-8310, RCFB58 c3.7, RCi200 and PGRN8310)

    Denmark H. Lundbeck A/S (LUB)
    Disease:

    Frontotemporal dementia

  626. LUMCi004-A (LUMC0099iCTRL04)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Normal (normalities, health, normalcy, normality)

  627. LUMCe001-A (HESC-NL1)

    Netherlands Leiden University Medical Center (LUMC)

  628. LUMCe002-A (HESC-NL2)

    Netherlands Leiden University Medical Center (LUMC)

  629. LUMCe003-A (HESC-NL3)

    Netherlands Leiden University Medical Center (LUMC)

  630. LUMCe004-A (HESC-NL4)

    Netherlands Leiden University Medical Center (LUMC)

  631. MHHi001-A (hHSC_Iso4_ADCF_SeViPS2 (Phönix))

    Germany Hannover Medical School (MHH)
    Disease:

    Normal (normalities, health, normalcy, normality)

  632. MHHi002-A (CF(1)iPS5)

    Germany Hannover Medical School (MHH)
    Disease:

    Cystic fibrosis

  633. MHHi003-A (CF(15)iPS10)

    Germany Hannover Medical School (MHH)
    Disease:

    Cystic fibrosis

  634. MHHi004-A (CF(16)iPS1)

    Germany Hannover Medical School (MHH)
    Disease:

    Cystic fibrosis

  635. MHHi005-A (CF(17)iPS6)

    Germany Hannover Medical School (MHH)
    Disease:

    Cystic fibrosis

  636. MHHi006-A (HSC1285_T-iPS2)

    Germany Hannover Medical School (MHH)
    Disease:

    Normal (normalities, health, normalcy, normality)

  637. MICCNi001-A (ADHD Stem Cell Study_subject 6, hiPSC_03 family control sibling and clone C1)

    Australia ​Monash Institute of Cognitive and Clinical Neurosciences (MICCN)
    Disease:

    Normal (normalities, health, normalcy, normality)

  638. MICCNi001-B (ADHD Stem Cell Study_subject 6, hiPSC_03 family control sibling and clone C2)

    Australia ​Monash Institute of Cognitive and Clinical Neurosciences (MICCN)
    Disease:

    Normal (normalities, health, normalcy, normality)

  639. MICCNi002-A (ADHD Stem Cell Study_subject 5, clone A1 and hiPSC_03 affected sibling)

    Australia ​Monash Institute of Cognitive and Clinical Neurosciences (MICCN)
    Disease:

    Attention deficit hyperactivity disorder

  640. MICCNi002-B (ADHD Stem Cell Study_subject 5, hiPSC_03 affected sibling and clone A16)

    Australia ​Monash Institute of Cognitive and Clinical Neurosciences (MICCN)
    Disease:

    Attention deficit hyperactivity disorder

  641. MIHe001-A (MB01)

    South Korea Maria Infertility Hospital (MIH)

  642. MIHe002-A (MB02)

    South Korea Maria Infertility Hospital (MIH)

  643. MIHe003-A (MB03)

    South Korea Maria Infertility Hospital (MIH)

  644. MIHe004-A (MB04)

    South Korea Maria Infertility Hospital (MIH)

  645. MIHe005-A (MB05)

    South Korea Maria Infertility Hospital (MIH)

  646. MIHe006-A (MB06)

    South Korea Maria Infertility Hospital (MIH)

  647. MIHe007-A (MB07)

    South Korea Maria Infertility Hospital (MIH)

  648. MIHe008-A (MB08)

    South Korea Maria Infertility Hospital (MIH)

  649. MIHe009-A (MB09)

    South Korea Maria Infertility Hospital (MIH)

  650. MIZMe001-A (Miz-hES1)

    South Korea MizMedi Hospital (MIZM)

  651. MIZMe002-A (Miz-hES2)

    South Korea MizMedi Hospital (MIZM)

  652. MIZMe003-A (Miz-hES3)

    South Korea MizMedi Hospital (MIZM)

  653. MIZMe004-A (Miz-hES9)

    South Korea MizMedi Hospital (MIZM)

  654. MIZMe005-A (Miz-hES14)

    South Korea MizMedi Hospital (MIZM)

  655. MIZMe006-A (Miz-hES15)

    South Korea MizMedi Hospital (MIZM)

  656. MIZMe007-A (Miz-hES4)

    South Korea MizMedi Hospital (MIZM)

  657. MIZMe008-A (Miz-hES5)

    South Korea MizMedi Hospital (MIZM)

  658. MIZMe009-A (Miz-hES6)

    South Korea MizMedi Hospital (MIZM)

  659. MIZMe010-A (Miz-hES7)

    South Korea MizMedi Hospital (MIZM)

  660. MIZMe011-A (Miz-hES8)

    South Korea MizMedi Hospital (MIZM)

  661. MIZMe012-A (Miz-hES10)

    South Korea MizMedi Hospital (MIZM)

  662. MIZMe013-A (Miz-hES11)

    South Korea MizMedi Hospital (MIZM)

  663. MIZMe014-A (Miz-hES12)

    South Korea MizMedi Hospital (MIZM)

  664. MIZMe015-A (Miz-hES13)

    South Korea MizMedi Hospital (MIZM)
    Disease:

    Patau syndrome

  665. MLi002-A (iEBS)

    Slovenia Faculty of Medicine University of Ljubljana (ML)
    Disease:

    Epidermolysis bullosa simplex

  666. ESIBIe003-A-4 (Envy)

    Australia Monash University (MONU)

  667. MPIi001-A

    Germany Max Planck Institute for Molecular Biomedicine (MPI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  668. MPIi002-A (T4 and L1-1Mut)

    Germany Max Planck Institute for Molecular Biomedicine (MPI)
    Disease:

    Parkinson's disease

  669. MPIi003-A (IM2 and L2-2Mut)

    Germany Max Planck Institute for Molecular Biomedicine (MPI)
    Disease:

    Parkinson's disease

  670. MPIi003-A-1 (IM2GC and L2-2GC)

    Germany Max Planck Institute for Molecular Biomedicine (MPI)
    Disease:

    Parkinson's disease

  671. MPIi005-A (SF2.1 and wt1)

    Germany Max Planck Institute for Molecular Biomedicine (MPI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  672. MSHRIe001-A (CA1)

    Canada Mount Sinai Hospital (MSHRI)

  673. MSHRIe002-A (CA2)

    Canada Mount Sinai Hospital (MSHRI)

  674. MUi010-A (MYH9)

    Thailand Mahidol University (MU)
    Disease:

    Myh9-related disease

  675. MUi015-A (RB1)

    Thailand Mahidol University (MU)
    Disease:

    Retinoblastoma

  676. MUNIi001-A (DMD02)

    Czech Republic Masaryk University (MUNI)
    Disease:

    Duchenne muscular dystrophy

  677. MUNIi002-A (MDMD02)

    Czech Republic Masaryk University (MUNI)
    Disease:

    Duchenne muscular dystrophy

  678. MUNIi003-A (DMD03)

    Czech Republic Masaryk University (MUNI)
    Disease:

    Duchenne muscular dystrophy

  679. MUNIi004-A (DMD04)

    Czech Republic Masaryk University (MUNI)
    Disease:

    Duchenne muscular dystrophy

  680. MUNIe001-A (CCTL 6)

    Czech Republic Masaryk University (MUNI)

  681. MUNIe001-A-1

    Czech Republic Masaryk University (MUNI)

  682. MUNIe002-A (CCTL 8)

    Czech Republic Masaryk University (MUNI)

  683. MUNIe002-A-1

    Czech Republic Masaryk University (MUNI)

  684. MUNIe003-A (CCTL 9)

    Czech Republic Masaryk University (MUNI)

  685. MUNIe003-A-1

    Czech Republic Masaryk University (MUNI)

  686. MUNIe004-A (CCTL 10)

    Czech Republic Masaryk University (MUNI)

  687. MUNIe004-A-1

    Czech Republic Masaryk University (MUNI)

  688. MUNIe005-A (CCTL 12)

    Czech Republic Masaryk University (MUNI)

  689. MUNIe005-A-1

    Czech Republic Masaryk University (MUNI)

  690. MUNIe006-A (CCTL 13)

    Czech Republic Masaryk University (MUNI)

  691. MUNIe006-A-1

    Czech Republic Masaryk University (MUNI)

  692. MUNIe007-A (CCTL 14)

    Czech Republic Masaryk University (MUNI)

  693. NERCe002-A (chHES-90)

    China National Engineering and Research Center of Human Stem Cell (NERC)
    Disease:

    Normal (normalities, health, normalcy, normality)

  694. NERCe002-A-1 (chHES-90-PLEX-ZsGreen)

    China National Engineering and Research Center of Human Stem Cell (NERC)
    Disease:

    Normal (normalities, health, normalcy, normality)

  695. NERCe002-A-2 (chHES-90-PLEX-Luciferase)

    China National Engineering and Research Center of Human Stem Cell (NERC)
    Disease:

    Normal (normalities, health, normalcy, normality)

  696. NERCe002-A-3 (chHES-90-pINDUCER20-tet-14-3-3ζ)

    China National Engineering and Research Center of Human Stem Cell (NERC)
    Disease:

    Normal (normalities, health, normalcy, normality)

  697. NERCe003-A (chHES-8)

    China National Engineering and Research Center of Human Stem Cell (NERC)
    Disease:

    Normal (normalities, health, normalcy, normality)

  698. NERCe003-A-1 (chHES-8-pINDUCER20-tet-CTNNB1)

    China National Engineering and Research Center of Human Stem Cell (NERC)
    Disease:

    Normal (normalities, health, normalcy, normality)

  699. NERCe003-A-2 (chHES-8-pINDUCER10-tet-shβ-catenin)

    China National Engineering and Research Center of Human Stem Cell (NERC)
    Disease:

    Normal (normalities, health, normalcy, normality)

  700. NERCe003-A-3 (chHES-8-KO-P53)

    China National Engineering and Research Center of Human Stem Cell (NERC)
    Disease:

    Normal (normalities, health, normalcy, normality)

  701. NIRRHe001-A (KIND-1)

    India National Institute for Research in Reproductive Health (NIRRH)

  702. NIRRHe002-A (KIND-2)

    India National Institute for Research in Reproductive Health (NIRRH)

  703. NTUe001-A (NTU1)

    Taiwan National Taiwan University (NTU)

  704. NTUe002-A (NTU2)

    Taiwan National Taiwan University (NTU)

  705. NTUe003-A (NTU3)

    Taiwan National Taiwan University (NTU)

  706. NUIGi001-A (iPSC ARO1-11)

    Ireland National University of Ireland Galway (NUIG)

  707. NYSCFi001-A (AL0002-01-MR-131)

    United States New York Stem Cell Foundation Research Institute (NYSCF)
    Disease:

    Normal (normalities, health, normalcy, normality)

  708. NYSCFi001-B (AL0002-01-MR-132)

    United States New York Stem Cell Foundation Research Institute (NYSCF)
    Disease:

    Normal (normalities, health, normalcy, normality)

  709. NYSCFi001-C (AL0002-01-SV-008)

    United States New York Stem Cell Foundation Research Institute (NYSCF)
    Disease:

    Normal (normalities, health, normalcy, normality)

  710. NYSCFi001-D (AL0002-01-SV-010)

    United States New York Stem Cell Foundation Research Institute (NYSCF)
    Disease:

    Normal (normalities, health, normalcy, normality)

  711. NYSCFi002-A (AL0004-01-SV-002)

    United States New York Stem Cell Foundation Research Institute (NYSCF)
    Disease:

    Normal (normalities, health, normalcy, normality)

  712. NYSCFi002-B (AL0004-01-SV-008)

    United States New York Stem Cell Foundation Research Institute (NYSCF)
    Disease:

    Normal (normalities, health, normalcy, normality)

  713. NYSCFe001-A (NY0001-01-ES-001)

    United States New York Stem Cell Foundation Research Institute (NYSCF)
    Disease:

    Normal (normalities, health, normalcy, normality)

  714. NYSCFe002-A (NY0002-01-ES-001)

    United States New York Stem Cell Foundation Research Institute (NYSCF)
    Disease:

    Normal (normalities, health, normalcy, normality)

  715. NYSCFe003-A (NY0003-01-ES-001)

    United States New York Stem Cell Foundation Research Institute (NYSCF)
    Disease:

    Normal (normalities, health, normalcy, normality)

  716. OSRi001-A (PD-OPA1-A495V#72)

    Italy Ospedale San Raffaele (OSR)
    Disease:

    Parkinson's disease

  717. OSRi004-A (ND#37)

    Italy Ospedale San Raffaele (OSR)
    Disease:

    Normal (normalities, health, normalcy, normality)

  718. PCIi001-A

    France PHENOCELL (PCI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  719. PCIi002-A

    France PHENOCELL (PCI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  720. PCIi003-A

    France PHENOCELL (PCI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  721. PCIi004-A

    France PHENOCELL (PCI)
    Disease:

    Normal (normalities, health, normalcy, normality)

  722. PCIi005-A

    France PHENOCELL (PCI)
    Disease:

    Danon disease

  723. PFIZi001-A (EM1-3F)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Erythromelalgia

  724. RCi001-A (Thp3C-6 and RCi88)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Erythromelalgia

  725. RCi001-B (RCi89 and Thp3C-9)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Erythromelalgia

  726. PFIZi002-A (EM1-7M)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Erythromelalgia

  727. RCi002-A (FP5C-14 and RCi92)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Erythromelalgia

  728. RCi002-B (FP5C-16 and RCi93)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Erythromelalgia

  729. PFIZi003-A (EM2-7M)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Erythromelalgia

  730. RCi003-A (RCi115 and CIP11A-5)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Pain agnosia

  731. RCi003-B (CIP11A-9 and RCi117)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Pain agnosia

  732. PFIZi004-A (EM2-7F)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Erythromelalgia

  733. PFIZi009-A (RCi188)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  734. PFIZi010-A (FB65c7)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Chromosome 16p11.2 deletion syndrome, 220kb

  735. PFIZi010-B (FB65c16)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Chromosome 16p11.2 deletion syndrome, 220kb

  736. PFIZi010-C (FB65c20)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Chromosome 16p11.2 deletion syndrome, 220kb

  737. PFIZi011-A (RCi199 and FB67c2)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Chromosome 16p11.2 deletion syndrome, 220kb

  738. PFIZi012-A (FB66c17 and RCi198)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Chromosome 16p11.2 deletion syndrome, 220kb

  739. PFIZi013-A (RCi215 and RCFB59 C9)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Amyotrophic lateral sclerosis

  740. PFIZi014-A (OD002-s7)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  741. PFIZi015-A (OD003-s5)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  742. PFIZi016-A (OD005-s9)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  743. PFIZi017-A (BC142c7 and RCi209)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  744. PFIZi018-A (BC143c8 and RCi207)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  745. PFIZi019-A (RCi202 and BC145c6)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  746. PFIZi021-A (OD001-s7)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  747. PFIZi022-A (B219c2)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  748. PFIZi023-A (B217c8)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  749. PFIZi024-A (B218c6)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  750. PFIZi025-A (B220c16)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  751. PFIZi027-A (B221c13)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  752. PFIZi028-A (B212c7)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  753. PFIZi029-A (B222c4)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  754. PFIZi030-A (B216c13)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  755. PFIZi031-A (B213c1)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  756. PFIZi032-A (B214c8)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Dravet syndrome

  757. POWHe001-A (Endeavour 1)

    Australia Prince of Wales Hospital (POWH)

  758. POWHe001-A-1 (E1C1)

    Australia Prince of Wales Hospital (POWH)

  759. POWHe001-A-2 (E1C2)

    Australia Prince of Wales Hospital (POWH)

  760. POWHe001-A-3 (E1C3)

    Australia Prince of Wales Hospital (POWH)

  761. POWHe001-A-4 (E1C4)

    Australia Prince of Wales Hospital (POWH)

  762. POWHe002-A (Endeavour 2)

    Australia Prince of Wales Hospital (POWH)

  763. RASe001-A (ESM01)

    Russia Russian Academy of Sciences (RAS)

  764. RASe002-A (ESM02)

    Russia Russian Academy of Sciences (RAS)

  765. RASe003-A (ESM03)

    Russia Russian Academy of Sciences (RAS)

  766. RBi001-A (fb101 and RB101)

    United Kingdom R Biomedical (RB)
    Disease:

    Normal (normalities, health, normalcy, normality)

  767. RCi004-A (PDSC-10 and RCi150)

    United Kingdom Roslin Cells (RC)
    Disease:

    Huntington disease

  768. RCi004-B (RCi68 and PDSC-3)

    United Kingdom Roslin Cells (RC)
    Disease:

    Huntington disease

  769. RCi005-A (FB71c4 and RCi171)

    United Kingdom Roslin Cells (RC)
    Disease:

    Facioscapulohumeral dystrophy

  770. RCi006-A (FB69c4 and RCi169)

    United Kingdom Roslin Cells (RC)
    Disease:

    Facioscapulohumeral dystrophy

  771. RCi007-C

    United Kingdom